Paratek Pharmaceuticals
MA - BostonPharmaceutical
Focus: Paratek is a specialty pharmaceutical company focused on small molecule antibiotics and respiratory therapeutics, headquartered in Boston. The company derives 100% of revenue from XHANCE (fluticasone propionate), indicating a single-product-dependent business model.
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Open Jobs
35+9 this month
Growing — net +9 jobs in 30d
10 jobs added vs 1 removed. Steady team buildout.
Should You Work at Paratek Pharmaceuticals?
AI assessmentBest suited for commercial, sales, and market access professionals seeking high-growth infectious disease exposure in a specialty-pharma turnaround; riskier for R&D and ops roles given single-product dependency.
Why Work Here
- Strong commercial infrastructure with 27 of 30 open roles in Commercial—signals aggressive market expansion and revenue-driving focus
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
8 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$18M Part DStable
Peak
Help build intelligence for Paratek Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.